38.17B
Market cap
33.8x
Current P/E
37.31x
Forward P/E

About

Health care
Sector
Medical - Diagnostics & Research
Industry

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals.

Similar securities

Based on sector and market capitalization

Report issue